​

HCA Healthcare (HCA) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

HCA Stock Forecast

HCA Healthcare stock forecast is as follows: an average price target of $413.20 (represents a 26.12% upside from HCA’s last price of $327.62) and a rating consensus of 'Buy', based on 24 wall street analysts offering a 1-year stock forecast.

HCA Price Target

The average price target for HCA Healthcare (HCA) is $413.20 based on 1-year price targets from 24 Wall Street analysts in the past 3 months, with a price target range of $441.00 to $370.00. This represents a potential 26.12% upside from HCA's last price of $327.62.

HCA Analyst Ratings

Buy

According to 24 Wall Street analysts, HCA Healthcare's rating consensus is 'Buy'. The analyst rating breakdown for HCA stock is 0 'Strong Buy' (0.00%), 18 'Buy' (75.00%), 6 'Hold' (25.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

HCA Healthcare Price Target by Analyst

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jan 07, 2025Matthew GillmorKeyBanc$370.00$308.2120.05%12.94%
Oct 28, 2024Michael WiederhornOppenheimer$400.00$359.0711.40%22.09%
Oct 28, 2024Matthew GillmorKeyBanc$420.00$359.0716.97%28.20%
Oct 28, 2024Ann HynesMizuho Securities$425.00$359.1618.33%29.72%
Oct 10, 2024Matthew GillmorKeyBanc$475.00$387.2522.66%44.99%
Oct 01, 2024Pito ChickeringDeutsche Bank$441.00$406.018.62%34.61%
Aug 19, 2024David MacDonaldTruist Financial$430.00$373.7715.04%31.25%
Jun 28, 2024Pito ChickeringDeutsche Bank$375.00$335.0411.93%14.46%
Jun 06, 2024Brian TanquilutJefferies$390.00$336.8215.79%19.04%
Apr 29, 2024Ben HendrixRBC Capital$329.00$311.075.76%0.42%
Apr 29, 2024Michael WiederhornOppenheimer$345.00$306.6912.49%5.30%
Apr 12, 2024Pito ChickeringDeutsche Bank$359.00$327.259.70%9.58%
Apr 24, 2023Ann HynesMizuho Securities$298.00$285.914.23%-9.04%
Apr 24, 2023Michael WiederhornOppenheimer$310.00$285.918.43%-5.38%
Apr 24, 2023Ben HendrixRBC Capital$315.00$285.9110.17%-3.85%
Feb 08, 2023Goldman Sachs$296.00$257.0915.13%-9.65%
Jan 13, 2023UBS$296.00$257.8514.80%-9.65%
Jan 03, 2023Wells Fargo$243.00$243.21-0.09%-25.83%
Dec 16, 2022Leerink Partners$286.00$239.7019.32%-12.70%
Dec 12, 2022Goldman Sachs$265.00$241.359.80%-19.11%
Sep 16, 2022Raymond James$250.00$208.9719.63%-23.69%
Aug 24, 2022Leerink Partners$259.00$210.2523.19%-20.94%
Aug 16, 2022Ann HynesMizuho Securities$230.00$213.477.74%-29.80%
Jul 28, 2022Wells Fargo$199.00$204.66-2.77%-39.26%
Jul 26, 2022Raymond James$230.00$198.6315.79%-29.80%
Jul 25, 2022RBC Capital$249.00$198.5325.42%-24.00%
Jul 25, 2022Credit Suisse$250.00$202.8723.23%-23.69%
Jul 25, 2022Truist Financial$240.00$202.0318.79%-26.74%
Jul 25, 2022Leerink Partners$240.00$202.0318.79%-26.74%
Jul 15, 2022Leerink Partners$212.00$167.4926.57%-35.29%
Jul 12, 2022Goldman Sachs$233.00$170.0237.04%-28.88%
Jul 11, 2022Raymond James$220.00$172.6027.46%-32.85%
Jul 07, 2022Deutsche Bank$200.00$172.7615.77%-38.95%
Jul 01, 2022Mizuho Securities$210.00$168.0624.96%-35.90%
Jun 21, 2022RBC Capital$256.00$173.1047.89%-21.86%
Jun 16, 2022Joseph FranceLoop Capital Markets$240.00$171.5639.89%-26.74%
May 03, 2022Mizuho Securities$260.00$215.6920.54%-20.64%
Apr 28, 2022Matt BorschBMO Capital$240.00$219.069.56%-26.74%
Apr 26, 2022UBS$241.00$210.9014.27%-26.44%
Apr 26, 2022Raymond James$245.00$210.5016.39%-25.22%
Apr 25, 2022Truist Financial$250.00$210.5618.73%-23.69%
Apr 25, 2022Wells Fargo$227.00$211.947.10%-30.71%
Apr 25, 2022Credit Suisse$260.00$208.7024.58%-20.64%
Apr 25, 2022Leerink Partners$273.00$210.6429.61%-16.67%
Apr 25, 2022Citigroup$254.00$210.6420.58%-22.47%
Apr 25, 2022RBC Capital$267.00$210.6426.76%-18.50%
Apr 25, 2022Steve BaxterWells Fargo$227.00$210.507.84%-30.71%
Apr 22, 2022Sarah JamesBarclays$256.00$210.6421.53%-21.86%
Apr 22, 2022Ann HynesMizuho Securities$290.00$210.6437.68%-11.48%
Jan 05, 2022David S MacdonaldTruist Financial$310.00$258.4319.96%-5.38%
Jan 04, 2022Brian TanquilutJefferies$310.00$259.7219.36%-5.38%
Dec 21, 2021Lisa GillJ.P. Morgan$270.00$246.519.53%-17.59%
Dec 20, 2021Ann HynesMizuho Securities$290.00$245.1018.32%-11.48%
Oct 26, 2021John RansomRaymond James$300.00$240.4224.78%-8.43%
Oct 25, 2021Pito ChickeringDeutsche Bank$306.00$240.8327.06%-6.60%
Oct 25, 2021Michael WiederhornOppenheimer$290.00$240.8320.42%-11.48%
Aug 16, 2021Sarah JamesBarclays$275.00$244.8512.31%-16.06%
Aug 02, 2021Jasper HellwegArgus Research$275.00$249.5110.22%-16.06%
Jun 21, 2021Justin LakeWolfe Research$224.00$206.858.29%-31.63%

The latest HCA Healthcare stock forecast, released on Jan 07, 2025 by Matthew Gillmor from KeyBanc, set a price target of $370.00, which represents a 20.05% increase from the stock price at the time of the forecast ($308.21), and a 12.94% increase from HCA last price ($327.62).

HCA Healthcare Price Target by Period

1M3M12M
# Anlaysts1112
Avg Price Target$370.00$370.00$396.58
Last Closing Price$327.62$327.62$327.62
Upside/Downside12.94%12.94%21.05%

In the current month, the average price target of HCA Healthcare stock is $370.00, according to 1 Wall Street analyst offering twelve months forecast. The average price target represents a 12.94% increase as opposed to HCA Healthcare's last price of $327.62. This month's average price target is down 0.00% compared to last quarter, and down -6.70% compared to last year.

Analyst Ratings Upgrades/Downgrades

DateCompanyPrevious RatingNew RatingRating Change
Jan 07, 2025KeyBancOverweightOverweightHold
Oct 28, 2024OppenheimerOutperformOutperformHold
Oct 28, 2024KeyBancOverweightOverweightHold
Oct 16, 2024Cowen & Co.BuyBuyHold
Oct 10, 2024KeyBancOverweightInitialise
Oct 01, 2024Deutsche BankBuyBuyHold
Sep 03, 2024Morgan StanleyEqual-WeightInitialise
Aug 23, 2024RBC CapitalOutperformOutperformHold
Jul 30, 2024Wells FargoEqual-WeightEqual-WeightHold
Jul 25, 2024Cantor FitzgeraldOverweightOverweightHold
Jul 24, 2024RBC CapitalOutperformOutperformHold
Jul 24, 2024OppenheimerOutperformOutperformHold
Jul 23, 2024Goldman SachsNeutralNeutralHold
Jul 14, 2024BernsteinMarket PerformMarket PerformHold
Jul 10, 2024BarclaysOverweightOverweightHold
Jun 28, 2024Deutsche BankBuyBuyHold
Jun 06, 2024JefferiesBuyBuyHold
May 14, 2024DBS BankBuyInitialise
Apr 30, 2024Cowen & Co.BuyBuyHold
Apr 29, 2024RBC CapitalOutperformOutperformHold
Apr 29, 2024OppenheimerOutperformOutperformHold
Apr 12, 2024Deutsche BankBuyBuyHold
Jul 11, 2023BenchmarkBuyBuyHold
Jun 06, 2023CFRABuyUpgrade
Apr 24, 2023Mizuho SecuritiesBuyBuyHold
Apr 24, 2023Loop Capital MarketsBuyBuyHold
Apr 24, 2023Credit SuisseOutperformOutperformHold
Apr 24, 2023CitigroupBuyBuyHold
Apr 24, 2023OppenheimerOutperformOutperformHold
Apr 21, 2023Cantor FitzgeraldOverweightInitialise
Feb 08, 2023Goldman SachsBuyBuyHold
Jan 13, 2023UBSBuyBuyHold
Jan 03, 2023Wells FargoEqual-WeightEqual-WeightHold
Dec 16, 2022SVB LeerinkOutperformOutperformHold
Dec 12, 2022Goldman SachsBuyBuyHold
Sep 16, 2022Raymond JamesOutperformOutperformHold
Aug 24, 2022SVB LeerinkOutperformOutperformHold
Jul 28, 2022Wells FargoEqual-WeightEqual-WeightHold
Jul 27, 2022CitigroupBuyBuyHold
Jul 25, 2022RBC CapitalOutperformOutperformHold
Jul 25, 2022Credit SuisseOutperformOutperformHold
Jul 22, 2022Deutsche BankHoldHoldHold
Jul 22, 2022BarclaysEqual-WeightDowngrade
Jul 22, 2022CitigroupUnderperformNeutralDowngrade
Jul 22, 2022SVB LeerinkMarket PerformMarket PerformHold
Jul 22, 2022BTIGNeutralDowngrade
Jul 15, 2022SVB LeerinkOutperformOutperformHold
Jul 12, 2022Goldman SachsBuyBuyHold
Jul 11, 2022Raymond JamesOutperformOutperformHold
Jul 07, 2022Deutsche BankBuyBuyHold
Jun 21, 2022RBC CapitalOutperformOutperformHold
May 26, 2022BernsteinOutperformUpgrade
Apr 28, 2022BMO CapitalMarket PerformMarket PerformHold
Apr 26, 2022UBSBuyBuyHold

HCA Healthcare's last stock rating was published by KeyBanc on Jan 07, 2025. The company gave HCA a "Overweight" rating, the same as its previous rate.

HCA Healthcare Financial Forecast

HCA Healthcare Revenue Forecast

Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20
Revenue-----------------$16.21B$15.86B$15.59B$15.50B$14.97B$14.82B$14.95B$15.06B$15.28B$14.44B$13.98B$14.29B$13.31B
Avg Forecast$21.51B$20.53B$20.53B$20.31B$20.39B$19.39B$19.37B$19.25B$19.40B$18.46B$18.44B$18.27B$18.23B$17.54B$17.05B$16.81B$16.51B$15.82B$15.63B$15.27B$15.63B$15.00B$14.72B$14.75B$15.35B$14.53B$13.61B$13.63B$13.99B$12.85B
High Forecast$21.81B$20.82B$20.82B$20.60B$20.67B$19.66B$19.64B$19.52B$19.67B$18.72B$18.70B$18.41B$18.40B$17.57B$17.05B$16.81B$16.78B$15.96B$15.85B$15.48B$15.89B$15.00B$14.72B$14.75B$15.35B$14.53B$13.61B$13.63B$13.99B$12.85B
Low Forecast$21.21B$20.24B$20.24B$20.03B$20.10B$19.11B$19.10B$18.98B$19.13B$18.20B$18.18B$18.06B$18.08B$17.51B$17.05B$16.81B$16.32B$15.39B$15.41B$15.05B$15.40B$15.00B$14.72B$14.75B$15.35B$14.53B$13.61B$13.63B$13.99B$12.85B
# Analysts585510755854111377491815910168109913999
Surprise %-----------------1.02%1.01%1.02%0.99%1.00%1.01%1.01%0.98%1.05%1.06%1.03%1.02%1.04%

HCA Healthcare's average Quarter revenue forecast for Dec 23 based on 9 analysts is $16.51B, with a low forecast of $16.32B, and a high forecast of $16.78B. HCA's average Quarter revenue forecast represents a 1.85% increase compared to the company's last Quarter revenue of $16.21B (Sep 23).

HCA Healthcare EBITDA Forecast

Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20
# Analysts585510755854111377491815910168109913999
EBITDA-----------------$2.88B$3.06B$3.17B$3.18B$2.90B$3.04B$2.94B$3.52B$4.07B$3.00B$2.90B$2.85B$1.96B
Avg Forecast$4.46B$4.25B$4.26B$4.21B$4.22B$4.02B$4.01B$3.99B$4.02B$3.83B$3.82B$3.79B$3.78B$3.63B$3.53B$3.44B$3.42B$3.28B$3.24B$3.13B$3.97B$2.99B$2.94B$2.85B$3.06B$2.90B$2.72B$2.19B$2.79B$2.56B
High Forecast$4.52B$4.31B$4.31B$4.27B$4.28B$4.07B$4.07B$4.05B$4.08B$3.88B$3.88B$3.82B$3.81B$3.64B$3.53B$4.13B$3.48B$3.31B$3.28B$3.76B$4.76B$2.99B$2.94B$3.42B$3.06B$2.90B$2.72B$2.63B$2.79B$2.56B
Low Forecast$4.39B$4.19B$4.20B$4.15B$4.17B$3.96B$3.96B$3.93B$3.96B$3.77B$3.77B$3.74B$3.75B$3.63B$3.53B$2.76B$3.38B$3.19B$3.19B$2.50B$3.17B$2.99B$2.94B$2.28B$3.06B$2.90B$2.72B$1.75B$2.79B$2.56B
Surprise %-----------------0.88%0.94%1.01%0.80%0.97%1.03%1.03%1.15%1.40%1.10%1.32%1.02%0.76%

9 analysts predict HCA's average Quarter EBITDA for Dec 23 to be $3.42B, with a high of $3.48B and a low of $3.38B. This is 18.82% upper than HCA Healthcare's previous annual EBITDA (Sep 23) of $2.88B.

HCA Healthcare Net Income Forecast

Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20
# Analysts585510755854111377491815910168109913999
Net Income-----------------$1.08B$1.19B$1.36B$2.08B$1.13B$1.16B$1.27B$2.00B$2.27B$1.45B$1.42B$1.43B$668.00M
Avg Forecast$2.33B$1.84B$2.07B$1.94B$2.12B$1.65B$1.84B$1.75B$1.90B$1.46B$1.63B$1.51B$1.59B$1.29B$1.28B$1.59B$1.31B$1.03B$1.10B$1.44B$2.04B$1.02B$976.94M$1.31B$1.19B$1.07B$835.19M$1.08B$942.06M$605.78M
High Forecast$2.37B$1.88B$2.11B$1.97B$2.16B$1.68B$1.88B$1.78B$1.93B$1.49B$1.66B$1.56B$1.65B$1.30B$1.28B$1.90B$1.40B$1.12B$1.12B$1.73B$2.45B$1.02B$976.94M$1.57B$1.19B$1.07B$835.19M$1.29B$942.06M$605.78M
Low Forecast$2.28B$1.81B$2.03B$1.90B$2.09B$1.62B$1.81B$1.71B$1.86B$1.43B$1.60B$1.45B$1.56B$1.28B$1.28B$1.27B$1.28B$963.33M$1.08B$1.15B$1.64B$1.02B$976.94M$1.05B$1.19B$1.07B$835.19M$861.49M$942.06M$605.78M
Surprise %-----------------1.04%1.08%0.94%1.02%1.11%1.18%0.97%1.68%2.12%1.74%1.32%1.51%1.10%

HCA Healthcare's average Quarter net income forecast for Dec 23 is $1.31B, with a range of $1.28B to $1.40B. HCA's average Quarter net income forecast represents a 21.59% increase compared to the company's last Quarter net income of $1.08B (Sep 23).

HCA Healthcare SG&A Forecast

Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20
# Analysts585510755854111377491815910168109913999
SG&A-----------------$7.56B$7.28B$7.08B$7.05B$6.90B$6.79B$6.94B$7.00B$7.09B$6.38B$6.30B$6.33B$6.10B
Avg Forecast$9.86B$9.41B$9.41B$9.31B$9.34B$8.89B$8.88B$8.82B$8.89B$8.46B$8.45B$8.37B$8.36B$8.04B$7.82B$8.65B$7.57B$7.25B$7.16B$7.87B$7.89B$6.87B$6.75B$7.15B$7.04B$6.66B$6.24B$4.77B$6.41B$5.89B
High Forecast$10.00B$9.54B$9.54B$9.44B$9.47B$9.01B$9.00B$8.95B$9.02B$8.58B$8.57B$8.44B$8.43B$8.05B$7.82B$10.38B$7.69B$7.31B$7.26B$9.44B$9.46B$6.87B$6.75B$8.58B$7.04B$6.66B$6.24B$5.72B$6.41B$5.89B
Low Forecast$9.72B$9.28B$9.28B$9.18B$9.21B$8.76B$8.75B$8.70B$8.77B$8.34B$8.33B$8.28B$8.29B$8.02B$7.82B$6.92B$7.48B$7.05B$7.06B$6.29B$6.31B$6.87B$6.75B$5.72B$7.04B$6.66B$6.24B$3.81B$6.41B$5.89B
Surprise %-----------------1.04%1.02%0.90%0.89%1.00%1.01%0.97%0.99%1.06%1.02%1.32%0.99%1.04%

HCA Healthcare's average Quarter SG&A projection for Dec 23 is $7.57B, based on 9 Wall Street analysts, with a range of $7.48B to $7.69B. The forecast indicates a 0.16% rise compared to HCA last annual SG&A of $7.56B (Sep 23).

HCA Healthcare EPS Forecast

Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20
# Analysts585510755854111377491815910168109913999
EPS-----------------$3.97$4.34$4.92$7.50$3.99$4.02$4.26$6.56$7.24$4.49$4.26$4.20$1.97
Avg Forecast$8.95$7.09$7.96$7.45$8.17$6.35$7.09$6.72$7.31$5.62$6.27$5.80$6.13$4.96$4.93$5.06$5.05$3.98$4.25$3.91$4.79$3.88$3.70$4.26$4.52$4.06$3.16$3.32$3.57$2.29
High Forecast$9.12$7.22$8.11$7.59$8.32$6.47$7.22$6.84$7.44$5.72$6.38$5.99$6.35$5.00$4.93$5.06$5.37$4.30$4.32$3.98$4.89$3.88$3.70$4.26$4.52$4.06$3.16$3.32$3.57$2.29
Low Forecast$8.79$6.96$7.81$7.32$8.02$6.24$6.96$6.59$7.18$5.51$6.15$5.57$6.00$4.92$4.93$5.06$4.91$3.71$4.17$3.84$4.70$3.88$3.70$4.26$4.52$4.06$3.16$3.32$3.57$2.29
Surprise %-----------------1.00%1.02%1.26%1.57%1.03%1.09%1.00%1.45%1.78%1.42%1.28%1.18%0.86%

According to 9 Wall Street analysts, HCA Healthcare's projected average Quarter EPS for Dec 23 is $5.05, with a low estimate of $4.91 and a high estimate of $5.37. This represents a 27.14% increase compared to HCA previous annual EPS of $3.97 (Sep 23).

HCA Healthcare Peer Comparison by Price Target

TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
ACHCAcadia Healthcare$43.74$81.5086.33%Buy
AMEDAmedisys$92.28$143.3855.37%Hold
CYHCommunity Health Systems$3.32$5.0050.60%Buy
UHSUniversal Health Services$187.18$274.0046.38%Hold
SGRYSurgery Partners$25.75$36.3341.09%Buy
HCAHCA Healthcare$327.62$413.2026.12%Buy
THCTenet Healthcare$139.37$167.6720.31%Buy
ENSGEnsign Group$140.58$167.3319.03%Buy
ADUSAddus HomeCare$126.27$146.2015.78%Buy
CCRNCross Country Healthcare$18.23$21.0015.19%Buy
EHCEncompass Health$95.57$107.5012.48%Buy
DVADaVita$173.77$145.00-16.56%Hold
FMSFresenius Medical Care AG & Co. KGaA$24.84$17.85-28.14%Hold

HCA Forecast FAQ

Is HCA Healthcare a good buy?

Yes, according to 24 Wall Street analysts, HCA Healthcare (HCA) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 18 'Buy' recommendations, accounting for 75.00% of HCA's total ratings.

What is HCA's price target?

HCA Healthcare (HCA) average price target is $413.2 with a range of $370 to $441, implying a 26.12% from its last price of $327.62. The data is based on 24 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will HCA Healthcare stock go up soon?

According to Wall Street analysts' prediction for HCA stock, the company can go up by 26.12% (from the last price of $327.62 to the average price target of $413.2), up by 34.61% based on the highest stock price target, and up by 12.94% based on the lowest stock price target.

Can HCA Healthcare stock reach $500?

HCA's average twelve months analyst stock price target of $413.2 does not support the claim that HCA Healthcare can reach $500 in the near future.

What is HCA Healthcare's current price target trend?

1 Wall Street analyst forecast a $370 price target for HCA Healthcare (HCA) this month, up 12.94% from its last price of $327.62. Compared to the last 3 and 12 months, the average price target increased by 12.94% and increased by 21.05%, respectively.

What are HCA Healthcare's analysts' financial forecasts?

HCA Healthcare's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $78.4B (high $79.5B, low $77.29B), average EBITDA is $16.25B (high $16.48B, low $16.02B), average net income is $7.37B (high $7.5B, low $7.23B), average SG&A $35.93B (high $36.43B, low $35.42B), and average EPS is $28.34 (high $28.85, low $27.82). HCA's analysts financial forecasts for the fiscal year (Dec 2027) are as follows: average revenue is $82.88B (high $84.05B, low $81.71B), average EBITDA is $17.18B (high $17.42B, low $16.93B), average net income is $8.17B (high $8.32B, low $8.02B), average SG&A $37.99B (high $38.52B, low $37.45B), and average EPS is $31.45 (high $32.02, low $30.87).

Did the HCA's actual financial results beat the analysts' financial forecasts?

Based on HCA Healthcare's last annual report (Dec 2022), the company's revenue was $60.23B, beating the average analysts forecast of $60.1B by 0.21%. Apple's EBITDA was $12.07B, missing the average prediction of $12.75B by -5.34%. The company's net income was $5.64B, beating the average estimation of $5.36B by 5.33%. Apple's SG&A was $27.68B, missing the average forecast of $28.66B by -3.40%. Lastly, the company's EPS was $20.34, beating the average prediction of $16.63 by 22.29%. In terms of the last quarterly report (Sep 2023), HCA Healthcare's revenue was $16.21B, beating the average analysts' forecast of $15.82B by 2.47%. The company's EBITDA was $2.88B, missing the average prediction of $3.28B by -12.17%. HCA Healthcare's net income was $1.08B, beating the average estimation of $1.03B by 4.43%. The company's SG&A was $7.56B, beating the average forecast of $7.25B by 4.20%. Lastly, the company's EPS was $3.97, missing the average prediction of $3.98 by -0.13%